Skip to main content
Equibles

UBS Group AG

Position in ABT — Abbott Laboratories

CIK 1610520 ZURICH, V8
Back to ABT Full portfolio

Position in ABT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,247,724,380
-$65,323,462 QoQ
Shares Held
12,152,765
+16.0% QoQ
Ownership
0.698%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 51.60443734409412.ToString("F0")% Shared 0.ToString("F0")% None 48.39556265590588.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2026
CallValue
$61,003,433
CallShares
594,170
PutValue
$301,962,737
PutShares
2,941,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,241,934,930 across 131 Medical Devices names. ABT ranks #1 (23.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
This page 		12,152,765 $1,247,724,380
2 BSX
Boston Scientific Corp
 14,824,662 $930,247,536
3 MDT
Medtronic plc
 6,412,252 $555,621,633
4 SYK
Stryker Corp
 1,646,714 $541,093,748
5 DXCM
Dexcom Inc
 4,349,959 $273,177,422
6 EW
Edwards Lifesciences Corp
 2,561,776 $205,147,019
7 GEHC
GE HealthCare Technologies Inc.
 2,805,315 $199,682,320
8 PEN
Penumbra Inc
 560,335 $183,997,200

All Filings in ABT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,247,724,380 12,152,765
2026-03-31 $301,962,737 2,941,100
2026-03-31 $61,003,433 594,170
2025-12-31 $61,028,759 487,100
2025-12-31 $1,313,047,842 10,480,069
2025-12-31 $32,815,956 261,920
2025-09-30 $75,100,158 560,700
2025-09-30 $38,477,881 287,277
2025-09-30 $1,314,583,458 9,814,719
2025-06-30 $1,199,154,874 8,816,667
2025-06-30 $58,443,497 429,700
2025-06-30 $40,636,659 298,777
2025-03-31 $1,299,825,938 9,798,914
2025-03-31 $65,011,765 490,100
2025-03-31 $45,681,609 344,377
2024-12-31 $78,439,183 693,477
2024-12-31 $80,647,430 713,000
2024-12-31 $1,027,519,513 9,084,250
2024-09-30 $81,323,333 713,300
2024-09-30 $962,255,339 8,440,096
2024-09-30 $101,990,723 894,577
2024-06-30 $57,387,103 552,277
2024-06-30 $775,815,955 7,466,230
2024-06-30 $51,456,232 495,200
2024-03-31 $59,746,174 525,657
2024-03-31 $891,972,988 7,847,730
2024-03-31 $71,412,578 628,300
2023-12-31 $793,772,332 7,211,523
2023-12-31 $59,372,858 539,410
2023-12-31 $85,419,603 776,048
2023-09-30 $30,178,460 311,600
2023-09-30 $19,360,315 199,900
2023-09-30 $700,714,975 7,235,054
2023-06-30 $784,356,816 7,194,614
2023-06-30 $28,105,356 257,800
2023-06-30 $32,553,372 298,600
2023-03-31 $13,751,108 135,800
2023-03-31 $734,629,043 7,254,879
2023-03-31 $20,282,378 200,300
2022-12-31 $757,245,121 6,897,214
2022-12-31 $21,211,428 193,200
2022-12-31 $9,946,974 90,600
2022-09-30 $20,242,192 209,200
2022-09-30 $23,154,668 239,300
2022-09-30 $568,966,793 5,880,186
2022-06-30 $7,529,445 69,300
2022-06-30 $666,556,445 6,134,896
2022-03-31 $6,131,048 51,800
2022-03-31 $3,811,192 32,200
2022-03-31 $753,387,550 6,365,221

Report a Problem

Category
Description
Email (optional, for follow-up)